Q1 2025 Zoetis Inc Earnings Call Transcript
Key Points
- Zoetis Inc (ZTS) reported strong 9% organic operational revenue growth in the first quarter of 2025.
- The International segment led with 11% organic operational revenue growth, showcasing the company's global scale and diversification.
- The Companion Animal portfolio grew 9% operationally, driven by sustained demand for market-leading franchises.
- The Livestock segment achieved 7% organic operational growth, with broad-based double-digit performance internationally.
- Zoetis Inc (ZTS) maintained its full-year organic operational revenue guidance range of 6% to 8%, reflecting confidence in its portfolio differentiation and execution capabilities.
- The US Livestock segment experienced a 2% organic operational decline, primarily due to aggressive price competition and timing of price adjustments.
- Adoption of the Osteoarthritis Pain franchise has been more gradual than initially expected, with pet owners taking a measured approach to managing chronic conditions.
- The company faces potential profitability impacts in the near term due to enacted tariffs, with a $20 million headwind reflected in guidance.
- Competitive pressures are increasing in key markets, with new entrants expected in the dermatology and parasiticide segments.
- The operating environment remains unpredictable, with macroeconomic, regulatory, and geopolitical uncertainties posing challenges.
Welcome to the first quarter 2025 financial results conference call and webcast for Zoetis. Hosting the call today is Steve Frank, Vice President of Investor Relations for Zoetis. The presentation materials and additional financial tables are currently posted on the Investor Relations section of zoetis.com. The presentation slides can be managed by you, the viewer, and will not be forwarded automatically. In addition, a replay of the call will be available approximately two hours after the conclusion of this call via dial-in or the Investor Relations section of zoetis.com. (Operator instructions)
It is now my pleasure to turn the floor over to Steve Frank. Steve, you may begin.
Thank you, operator. Good morning, everyone, and welcome to the Zoetis first quarter 2025 earnings call. I am joined today by Kristin Peck, our Chief Executive Officer, and Wetteny Joseph, our Chief Financial Officer. Before we begin, I'll remind you that the slides presented on this call are available on the Investor
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
